Chih‐Che Lin

849 total citations
42 papers, 614 citations indexed

About

Chih‐Che Lin is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Chih‐Che Lin has authored 42 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 20 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Chih‐Che Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (15 papers) and Liver Disease and Transplantation (12 papers). Chih‐Che Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (15 papers) and Liver Disease and Transplantation (12 papers). Chih‐Che Lin collaborates with scholars based in Taiwan, United States and United Kingdom. Chih‐Che Lin's co-authors include Chao‐Long Chen, Chih‐Chi Wang, Yu‐Fan Cheng, Yaw‐Sen Chen, Chee‐Chien Yong, Yueh‐Wei Liu, Ming‐Lung Yu, Chih‐Chi Wang, Yi‐Hao Yen and Chih‐Wen Lin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Chih‐Che Lin

39 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih‐Che Lin Taiwan 15 335 290 151 106 97 42 614
Huaming Wang China 11 257 0.8× 177 0.6× 83 0.5× 53 0.5× 101 1.0× 29 583
Valery Vilchez United States 11 144 0.4× 140 0.5× 153 1.0× 101 1.0× 147 1.5× 27 611
Michael F. Daily United States 17 268 0.8× 112 0.4× 347 2.3× 137 1.3× 244 2.5× 34 947
Emily Bellavance United States 15 80 0.2× 79 0.3× 156 1.0× 159 1.5× 186 1.9× 36 651
James M. McGill United States 12 396 1.2× 346 1.2× 199 1.3× 17 0.2× 197 2.0× 21 840
WY Chang Taiwan 10 278 0.8× 267 0.9× 21 0.1× 28 0.3× 71 0.7× 10 409
Stefanie Bertram Germany 13 106 0.3× 165 0.6× 84 0.6× 52 0.5× 93 1.0× 28 492
Xiaoqiang Qiu China 13 37 0.1× 76 0.3× 41 0.3× 138 1.3× 82 0.8× 37 408
Hakan Yüceyar Türkiye 13 38 0.1× 57 0.2× 126 0.8× 26 0.2× 51 0.5× 36 357

Countries citing papers authored by Chih‐Che Lin

Since Specialization
Citations

This map shows the geographic impact of Chih‐Che Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Che Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Che Lin more than expected).

Fields of papers citing papers by Chih‐Che Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Che Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Che Lin. The network helps show where Chih‐Che Lin may publish in the future.

Co-authorship network of co-authors of Chih‐Che Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Che Lin. A scholar is included among the top collaborators of Chih‐Che Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Che Lin. Chih‐Che Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nakano, Toshiaki, Chao‐Long Chen, I‐Hsuan Chen, et al.. (2023). Overexpression of miR-4669 Enhances Tumor Aggressiveness and Generates an Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma: Its Clinical Value as a Predictive Biomarker. International Journal of Molecular Sciences. 24(9). 7908–7908. 15 indexed citations
3.
Yen, Yi‐Hao, Yueh‐Wei Liu, Weifeng Li, et al.. (2023). Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma. Cancers. 15(4). 1203–1203. 8 indexed citations
4.
Liu, Yueh‐Wei, Sin‐Hua Moi, Weifeng Li, et al.. (2023). A preoperative model for predicting early recurrence in patients undergoing resection for single hepatocellular carcinoma. European Journal of Surgical Oncology. 49(8). 1444–1449. 4 indexed citations
5.
6.
Kuo, Fang‐Ying, Hock‐Liew Eng, Weifeng Li, et al.. (2022). Tumor Necrosis Is an Indicator of Poor Prognosis Among Hepatoma Patients Undergoing Resection. Journal of Surgical Research. 283. 1091–1099. 4 indexed citations
7.
Kee, Kwong‐Ming, Chien‐Hung Chen, Jui‐Ting Hu, et al.. (2022). Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019. Viruses. 15(1). 126–126. 5 indexed citations
8.
Yen, Yi‐Hao, Yu‐Fan Cheng, Jing‐Houng Wang, et al.. (2021). Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias. PLoS ONE. 16(3). e0249194–e0249194. 12 indexed citations
9.
Tsai, Ming‐Chao, Chih‐Chi Wang, Wei‐Chen Lee, et al.. (2021). Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection. Liver Cancer. 11(1). 22–37. 15 indexed citations
10.
Wang, Chih‐Chi, Kuang‐Den Chen, Yueh‐Wei Liu, et al.. (2021). Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma. BMC Cancer. 21(1). 70–70. 15 indexed citations
11.
Wang, Chih‐Chi, Kuang‐Tzu Huang, Kuang‐Den Chen, et al.. (2021). HCV RNA in serum and liver samples of patients undergoing living donor liver transplantation. Journal of International Medical Research. 49(8). 3619095873–3619095873. 1 indexed citations
12.
Slovin, Susan F., Syed A. Hussain, Fred Saad, et al.. (2019). Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer. Clinical Cancer Research. 25(15). 4624–4633. 31 indexed citations
13.
Huang, Pao‐Yuan, Chih‐Chi Wang, Chih‐Che Lin, et al.. (2019). Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy. Journal of Clinical Medicine. 8(10). 1676–1676. 24 indexed citations
14.
Li, Lung‐Chih, Chien‐Ning Hsu, Chih‐Che Lin, et al.. (2017). Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients. BMC Gastroenterology. 17(1). 58–58. 12 indexed citations
15.
Huang, Kuang‐Tzu, I‐Ying Kuo, Ming‐Chao Tsai, et al.. (2017). Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma. Molecular Therapy — Nucleic Acids. 9. 274–283. 22 indexed citations
16.
Lin, Chih‐Che. (2015). Active vaccination to preventde novohepatitis B virus infection in liver transplantation. World Journal of Gastroenterology. 21(39). 11112–11112. 14 indexed citations
17.
Chen, Chao‐Long, Chee‐Chien Yong, Fang‐Ying Kuo, et al.. (2012). Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma. Surgical Oncology. 22(1). 55–60. 16 indexed citations
18.
Lin, Ting‐Lung, Jing‐Houng Wang, Chao‐Long Chen, et al.. (2011). Long term survival in patients with hepatocellular carcinoma directly invading the gastrointestinal tract: Case reports and literature review. Surgical Oncology. 20(4). e207–e214. 9 indexed citations
19.
Liu, Yueh‐Wei, Chao‐Long Chen, Yaw‐Sen Chen, et al.. (2006). Needle Tract Implantation of Hepatocellular Carcinoma After Fine Needle Biopsy. Digestive Diseases and Sciences. 52(1). 228–231. 24 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huaming Wang Breakdown of academic impact, for papers by Valery Vilchez Breakdown of academic impact, for papers by Michael F. Daily Breakdown of academic impact, for papers by Emily Bellavance Breakdown of academic impact, for papers by James M. McGill Breakdown of academic impact, for papers by WY Chang Breakdown of academic impact, for papers by Stefanie Bertram Breakdown of academic impact, for papers by Xiaoqiang Qiu Breakdown of academic impact, for papers by Hakan Yüceyar
Rankless by CCL
2026